Last reviewed · How we verify

Preoperative midazolam

Medical University of South Carolina · FDA-approved active Small molecule Quality 5/100

Preoperative midazolam is a Small molecule drug developed by Medical University of South Carolina. It is currently FDA-approved.

At a glance

Generic namePreoperative midazolam
SponsorMedical University of South Carolina
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Preoperative midazolam

What is Preoperative midazolam?

Preoperative midazolam is a Small molecule drug developed by Medical University of South Carolina.

Who makes Preoperative midazolam?

Preoperative midazolam is developed and marketed by Medical University of South Carolina (see full Medical University of South Carolina pipeline at /company/medical-university-of-south-carolina).

What development phase is Preoperative midazolam in?

Preoperative midazolam is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing